Hemispherx Biopharma (NYSE MKT: HEB) (the “Company), announced today that it will effect a 1-for-12 reverse stock split of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE